Werewolf Therapeutics, Inc. (HOWL)

Last Closing Price: 1.28 (2025-05-29)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Werewolf Therapeutics, Inc. (HOWL) had Net Income of $-70.52M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$1.89M
Net Income
$-70.52M
--
$1.89M
$75.48M
$-73.59M
$3.08M
$-70.52M
$-70.52M
$-70.52M
$-70.52M
$-70.52M
$-70.52M
$-73.59M
$-71.78M
43.33M
43.86M
$-1.63
$-1.63
Balance Sheet Financials
$113.07M
$6.32M
$13.86M
$126.93M
$15.18M
$26.09M
$38.36M
$53.54M
$73.39M
$73.39M
$73.39M
44.83M
Cash Flow Statement Financials
$-56.19M
$-0.25M
$13.08M
$155.58M
$112.22M
$-43.36M
$8.83M
--
--
Fundamental Metrics & Ratios
7.45
--
--
0.26
0.36
100.00%
-3904.19%
-3904.19%
-3807.96%
-3740.85%
-3740.85%
$-56.44M
--
--
--
0.01
--
--
--
-96.08%
-96.08%
-55.55%
-70.88%
$1.64
$-1.29
$-1.28